Research summary
Research summary
09/26/2024
Jessica Ganga
Researchers sought to determine the reliability of the use of transvaginal ultrasonography triage to diagnose endometrial cancer in patients who are Black and at risk for the disease.
09/26/2024
Research Summary
Research Summary
09/26/2024
Miranda Manier, BA
Researchers conducted a cross-sectional clinical trial with 8920 participants to evaluate whether a multitarget stool RNA test could serve as a noninvasive tool for detecting colorectal cancer, offering an...
09/26/2024
Research summary
Research summary
09/23/2024
Jessica Ganga
A first-time analysis using the National Inpatient Sample (NIS) database sought to examine the relationship between polycystic ovary syndrome (PCOS) and gynecologic cancers, including endometrial cancer. ...
09/23/2024
research summary
research summary
09/23/2024
Anthony Calabro, MA
Researchers conducted a meta-analysis examining the current evidence on the safety, efficacy, and predictive factors for venetoclax-based regimens in older adults with acute myeloid leukemia.
09/23/2024
Conference Coverage
Conference Coverage
09/19/2024
Jessica Ganga
In this retrospective study, researchers assessed the turnaround time of mutational tests in patients with newly diagnosed acute myeloid leukemia (AML) and the time from diagnosis to treatment initiation....
09/19/2024
Research Summary
Research Summary
09/18/2024
Anthony Calabro, MA
Researchers developed a population-based cohort study to determine whether there are associations between endometriosis subtypes and incidence of ovarian cancer.
09/18/2024
FDA ALERT
FDA ALERT
09/13/2024
Jessica Ganga
In June, following a placebo-controlled trial, the FDA approved pembrolizumab with chemotherapy to treat patients with primary advanced or recurrent endometrial carcinoma.
09/13/2024
Conference Coverage
Conference Coverage
05/31/2024

Jessica Ganga

Jessica Ganga
Patients with melanoma and who are being treated with PD-1 inhibitors have an increased risk of experiencing immune-related neurologic adverse events, compared with patients who are not being treated with...
05/31/2024
FDA Alert
FDA Alert
04/22/2024

Anthony Calabro, MA

Anthony Calabro, MA
The FDA previously approved lisocabtagene maraleucel as a second-line treatment option for adult patients with large B-cell lymphoma in June 2022.
04/22/2024
research summary
research summary
03/26/2024

Leigh Precopio

Leigh Precopio
Researchers examined if venetoclax—a therapy commonly used in the treatment of acute myelogenous leukemia and chronic lymphocytic leukemia—was associated with an increased risk of opportunistic infections,...
03/26/2024